Search research articles
Contact Us
Filters
Showing results (41-50 of 134) with videos related to
Page
of 14
Sort By:
AJR. American Journal of Roentgenology
|
January 23, 2010
Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses
Chaan S Ng, David L Raunig, Edward F Jackson, et al.
The American Journal of Dermatopathology
|
July 2, 2013
Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men
Jane H Zhou, Kevin B Kim, Jeffrey N Myers, et al.
Head & Neck
|
September 18, 2008
Biochemotherapy in patients with advanced head and neck mucosal melanoma
Holly L Bartell, Agop Y Bedikian, Nicholas E Papadopoulos, et al.
Pathology Oncology Research : POR
|
October 8, 2024
Higher Nodal expression is often associated with poorer survival in patients diagnosed with melanoma and treated with anti-PD1 therapy
Philippe D Gascard, Xianhong Wang, Mehdi Nosrati, et al.
Clinical & Experimental Metastasis
|
May 7, 2021
Current management of melanoma patients with nodal metastases
Dale Han, Alexander C J van Akkooi, Richard J Straker, et al.
Melanoma Research
|
May 16, 2012
Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases
Gladys Alvarado, Rahat Noor, Roland Bassett, et al.
Investigational New Drugs
|
April 21, 2017
A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
Jeffrey R Infante, Roger B Cohen, Kevin B Kim, et al.
American Journal of Clinical Oncology
|
December 15, 2010
Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma
Agop Y Bedikian, Caimiao Wei, Michelle Detry, et al.
Investigational New Drugs
|
July 6, 2017
Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
Jeffrey R Infante, Roger B Cohen, Kevin B Kim, et al.
BMC Cancer
|
March 8, 2017
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
Patricia M LoRusso, Jeffrey R Infante, Kevin B Kim, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 134) with videos related to
Sort By:
Page
of 14
AJR. American Journal of Roentgenology
|
January 23, 2010
Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses
Chaan S Ng, David L Raunig, Edward F Jackson, et al.
The American Journal of Dermatopathology
|
July 2, 2013
Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men
Jane H Zhou, Kevin B Kim, Jeffrey N Myers, et al.
Head & Neck
|
September 18, 2008
Biochemotherapy in patients with advanced head and neck mucosal melanoma
Holly L Bartell, Agop Y Bedikian, Nicholas E Papadopoulos, et al.
Pathology Oncology Research : POR
|
October 8, 2024
Higher Nodal expression is often associated with poorer survival in patients diagnosed with melanoma and treated with anti-PD1 therapy
Philippe D Gascard, Xianhong Wang, Mehdi Nosrati, et al.
Clinical & Experimental Metastasis
|
May 7, 2021
Current management of melanoma patients with nodal metastases
Dale Han, Alexander C J van Akkooi, Richard J Straker, et al.
Melanoma Research
|
May 16, 2012
Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases
Gladys Alvarado, Rahat Noor, Roland Bassett, et al.
Investigational New Drugs
|
April 21, 2017
A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
Jeffrey R Infante, Roger B Cohen, Kevin B Kim, et al.
American Journal of Clinical Oncology
|
December 15, 2010
Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma
Agop Y Bedikian, Caimiao Wei, Michelle Detry, et al.
Investigational New Drugs
|
July 6, 2017
Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
Jeffrey R Infante, Roger B Cohen, Kevin B Kim, et al.
BMC Cancer
|
March 8, 2017
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
Patricia M LoRusso, Jeffrey R Infante, Kevin B Kim, et al.
Page
of 14